Research on the use of medicinal plant materials and herbal-based medicines in the treatment of children, pregnant and breastfeeding women

Authors

DOI:

https://doi.org/10.15587/2519-4852.2026.359138

Keywords:

medicinal plants, herbal treatment, childhood, pregnant women, breastfeeding women, potential risks

Abstract

Plants have been the primary therapeutic agents for humanity for millennia. Parents are increasingly seeking alternative treatments that appear safer to improve their children's health, utilizing Herbal Medicine Substances (HMS).

The aim of the study was to provide evidence-based information for physicians and the public on the most commonly used medicinal plant materials and herbal remedies for treating children, pregnant women, and breastfeeding mothers, and to assess potential risks.

Materials and Methods. Data were collected about 713 children under the age of 12, represented by 678 respondents, and 383 of them about pregnancy and 385 women about breastfeeding. The study analyzed information on the herbal remedies used, their frequency of application, indications for use, treatment efficacy, and potential side effects of herbal preparations. The study examined seven specific objects: linden flowers (Tiliae flos), garlic bulbs (Allii sativi bulbus), chamomile flowers (Matricariae flos), calendula flowers (Calendulae flos), aloe leaves (Aloe folium), mint leaves (Menthae piperitae folium), and blueberry fruits (Myrtilli fructus). The analysis of the current state of HMS research was conducted based on data from PubMed, Embase, Best Evidence, EMA, and the British Medical Journal.

Results. Within the studied continuum, 81% of children used medicinal plant materials or herb-based preparations. The predominant indications for use were respiratory infections (colds) and digestive disorders. It was established that the use of herbal remedies only partially complied with the recommendations of the European Medicines Agency (EMA). For instance, 54% of children used aloe leaves to treat skin inflammation, which the EMA does not recommend for this age group. The study also revealed the use of medicinal plant materials not recommended by the EMA, specifically coltsfoot leaves, St. John's wort herb, and ginkgo biloba leaves. Side effects were recorded in 2.6% of children, most frequently associated with the use of garlic bulbs and mint leaves. Furthermore, the use of raw materials not recommended during pregnancy and lactation, such as motherwort herb, was identified. The systematized data served as the basis for recommendations for physicians and the public regarding the core criteria of phytotherapy in pediatrics, and for pregnant and breastfeeding women.

Conclusions. Since medicinal plant materials and herb-based preparations play a significant role in pediatric treatment, as well as during pregnancy and lactation, and study results indicate the use of products not recommended by the EMA, there is an urgent need to inform physicians and the general public about the correct application of herbal remedies and the potential risks associated with their use

Supporting Agency

  • European Union in the MSCA4Ukraine project “Design and development of 3D-printed medicines for bioactive materials of Ukrainian and Estonian medicinal plants origin” [ID number 1232466]

Author Biographies

Ain Raal, University of Tartu

PhD, Professor

Institute of Pharmacy

Elen Nikker, University of Tartu

Master Student of the Pharmacy

Institute of Pharmacy

Tetiana Ilina, Ivano-Frankivsk National Medical University

Doctor of Pharmaceutical Sciences, Professor

Department of Pharmaceutical Management, Drug Technology and Pharmacognosy

Alla Kovalyova, National University of Pharmacy

Doctor of Pharmaceutical Sciences, Professor

Department of Pharmacognosy

Oleh Koshovyi, University of Tartu; Zaporizhia State Medical and Pharmaceutical University

Doctor of Pharmaceutical Sciences, Professor

Institute of Pharmacy

Professor

Department of Clinical Pharmacy, Pharmacotherapy, Pharmacognosy and Pharmaceutical Chemistry

References

  1. Lie, Y. (2024). The Rise of Herbal Medicines: A Global Perspective. Journal of Basic and Clinical Pharmacy, 15 (5), 386.
  2. Bareetseng, S. (2022). The Worldwide Herbal Market: Trends and Opportunities. Journal of Biomedical Research & Environmental Sciences, 3 (5), 575–584. https://doi.org/10.37871/jbres1482
  3. Herbal Nutraceuticals Market Size and Share Forecast Outlook 2025 to 2035.. Global Market Analysis Report – 2035. Herbal Nutraceuticals Market. Available at: https://www.futuremarketinsights.com/reports/herbal-nutraceuticals-market
  4. Leach, M. J., Veziari, Y., Flanagan, C., Schloss, J. (2024). Prevalence of Complementary Medicine Use in Children and Adolescents: A Systematic Review. Journal of Pediatric Health Care, 38 (4), 505–519. https://doi.org/10.1016/j.pedhc.2023.12.010
  5. Rigillo, G., Blom, J. M. C., Cocchi, A., Martinucci, V., Favaro, F., Baini, G. et al. (2025). Medicinal Plants for Child Mental Health: Clinical Insights, Active Compounds, and Perspectives for Rational Use. Children, 12 (9), 1142. https://doi.org/10.3390/children12091142
  6. Raal, A., Volmer, D., Sõukand, R., Hratkevitš, S., Kalle, R. (2013). Complementary Treatment of the Common Cold and Flu with Medicinal Plants – Results from Two Samples of Pharmacy Customers in Estonia. PLoS ONE, 8 (3), e58642. https://doi.org/10.1371/journal.pone.0058642
  7. Sepp, J., Shepeleva, O., Kask, A., Nelis, G., Huttunen, A.-P., Kogermann, K. et al. (2024). Production, marketing and consumption of herbal drugs in Estonia. Journal of Applied Research on Medicinal and Aromatic Plants, 40, 100544. https://doi.org/10.1016/j.jarmap.2024.100544
  8. Villako, P., Volmer, D., Raal, A. (2012). Factors influencing purchase of and counselling about prescription and OTC medicines at community pharmacies in Tallinn, Estonia. Acta Poloniae Pharmaceutica, 69 (2), 335–340.
  9. Volmer, D., Raal, A., Kalle, R., Sõukand, R. (2016). The use of Panax ginseng and its analogues among pharmacy customers in estonia: a cross-sectional study. Acta Poloniae Pharmaceutica, 73 (3), 795–802.
  10. WHO global report on traditional, complementary and integrative medicine 2024 (2025). WHO. Available at: https://www.who.int/publications/i/item/9789240111387
  11. Hensel, A., Bauer, R., Heinrich, M., Hempel, G., Kelber, O., Kraft, K. et al. (2024). Rationalising Optimal Dosing of Phytotherapeutics For Use In Children: Current Status – Potential Solutions – Actions Needed. Planta Medica, 90 (6), 416–425. https://doi.org/10.1055/a-2294-5259
  12. Polat, S., Gürol, A.; Akram, M. (Ed.) (2021). Safety of Herbal Medicines in Children. Alternative Medicine – Update. IntechOpen. https://doi.org/10.5772/intechopen.94545
  13. Du, Y., Wolf, I.-K., Zhuang, W., Bodemann, S., Knöss, W., Knopf, H. (2014). Use of herbal medicinal products among children and adolescents in Germany. BMC Complementary and Alternative Medicine, 14 (1). https://doi.org/10.1186/1472-6882-14-218
  14. Stierman, B., Mishra, S., Gahche, J. J., Potischman, N., Hales, C. M. (2020). Dietary Supplement Use in Children and Adolescents Aged ≤19 Years — United States, 2017–2018. MMWR. Morbidity and Mortality Weekly Report, 69 (43), 1557–1562. https://doi.org/10.15585/mmwr.mm6943a1
  15. Petran, M., Dragoș, D., Stoian, I., Vlad, A., Gilca, M. (2024). Current use of medicinal plants for children’s diseases among mothers in Southern Romania. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1377341
  16. Mancak Karakuş, M., Tapisiz, A., Mutlu Karakaş, N., Deniz, M., Koca Çalişkan, U. (2023). Use of Herbal Tea/Herbal Preparations for Children with Symptoms of Viral Upper Respiratory Infections. Turkish Journal of Pharmaceutical Sciences, 20 (1), 8–15. https://doi.org/10.4274/tjps.galenos.2022.65475
  17. Popova, A., Mihaylova, D., Spasov, A. (2021). Plant-based Remedies with Reference to Respiratory Diseases – A Review. The Open Biotechnology Journal, 15 (1), 46–58. https://doi.org/10.2174/1874434602015010046
  18. Tervisestatistika ja terviseuuringute andmebaas. Available at: https://statistika.tai.ee/pxweb/et/Andmebaas/
  19. Common Cold in Children. Stanford Medicine Children’s Health. Available at: https://www.stanfordchildrens.org/en/topic/default%3Fid%3Dcommon-cold-in-children-90-P02966
  20. Long, S. S., Prober, C. G., Fischer, M. (2018). Principles and Practice of Pediatric Infectious Diseases. Elsevier. https://doi.org/10.1016/C2013-0-19020-4
  21. Illamola, S. M., Amaeze, O. U., Krepkova, L. V., Birnbaum, A. K., Karanam, A., Job, K. M. et al. (2020). Use of Herbal Medicine by Pregnant Women: What Physicians Need to Know. Frontiers in Pharmacology, 10. https://doi.org/10.3389/fphar.2019.01483
  22. Devi, P., Kumar, P.; Izah, S. C., Ogwu, M. C., Akram, M. (Eds.) (2023). Herbal Medicine and Pregnancy. Herbal Medicine Phytochemistry. Cham: Springer International Publishing, 1–31. https://doi.org/10.1007/978-3-031-21973-3_25-1
  23. Im, H. B., Hwang, J. H., Choi, D., Choi, S. J., Han, D. (2024). Patient–physician communication on herbal medicine use during pregnancy: a systematic review and meta-analysis. BMJ Global Health, 9 (3), e013412. https://doi.org/10.1136/bmjgh-2023-013412
  24. Regulatory Situation of Herbal Medicines. A worldwide Review (1998). WHO. Available at: https://www.who.int/publications/i/item/WHO-TRM-98.1
  25. Sethi, S. S., Bhardwaj, T., Sethi, S. K., Kaur, S., Rimpi, Baldi, A. (2025). Advancing herbal medicine safety: the need for a global pharmacovigilance approach. Naunyn-Schmiedeberg’s Archives of Pharmacology, 398 (10), 13499–13514. https://doi.org/10.1007/s00210-025-04066-2
  26. Sujithra, M., Puthiyedath, R., Pillai, Z. S. (2025). Drug–herb interactions: a challenge and clinical concern in primary healthcare. Frontiers in Pharmacology, 12. https://doi.org/10.3389/fmed.2025.1657005
  27. Gupta, A., Kumari, K., Hasan, F., Kumar, V., Kumar, P. (2024). Herb-Drug Interactions: A Critical Exploration in Modern Healthcare Practices. Journal of Medicinal Natural Products. https://doi.org/10.53941/jmnp.2025.100014
  28. Jovanović, M., Vučićević, K. (2022). Pediatric pharmacokinetic considerations and implications for drug dosing. Arhiv Za Farmaciju, 72 (3), 340–352. https://doi.org/10.5937/arhfarm72-37605
  29. Ekor, M. (2014). The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Frontiers in Pharmacology, 4. https://doi.org/10.3389/fphar.2013.00177
  30. Başaran, N., Paslı, D., Başaran, A. A. (2022). Unpredictable adverse effects of herbal products. Food and Chemical Toxicology, 159, 112762. https://doi.org/10.1016/j.fct.2021.112762
  31. Sartori, D., Aronson, J. K., Brand, J. S., Gauffin, O., Hedfors Vidlin, S., Norén, G. N., Onakpoya, I. J. (2025). Signals of Adverse Reactions to Herbal Medicines: Evidence and Document Analysis Based on a Scoping Review. Drug Safety, 48 (12), 1339–1352. https://doi.org/10.1007/s40264-025-01580-3
  32. Di Lorenzo, C., Ceschi, A., Kupferschmidt, H., Lüde, S., De Souza Nascimento, E., Dos Santos, A. et al. (2015). Adverse effects of plant food supplements and botanical preparations: a systematic review with critical evaluation of causality. British Journal of Clinical Pharmacology, 79 (4), 578–592. https://doi.org/10.1111/bcp.12519
  33. Lombardi, N., Crescioli, G., Bettiol, A., Menniti-Ippolito, F., Maggini, V., Gallo, E. et al. (2019). Safety of complementary and alternative medicine in children: A 16-years retrospective analysis of the Italian Phytovigilance system database. Phytomedicine, 61, 152856. https://doi.org/10.1016/j.phymed.2019.152856
  34. Committee on Herbal Medicinal Products. European Union herbal monographs: Overview of recommendations for the uses of herbal medicinal products in the paediatric population (2023). EMA. Paediatric uses of herbal medicines. Available at: https://www.ema.europa.eu/en/documents/other/european-union-herbal-monographs-overview-recommendations-uses-herbal-medicinal-products-paediatric-population_en.pdf
  35. Lowance, M., Franco, J., Wang, E., Milanaik, R. (2025). Navigating nature’s remedies: herbal and botanically derived complementary alternative medicine for children. Current Opinion in Pediatrics, 37 (5), 495–507. https://doi.org/10.1097/mop.0000000000001493
  36. Barnes, L. A. J., Barclay, L., McCaffery, K., Aslani, P. (2019). Women’s health literacy and the complex decision‐making process to use complementary medicine products in pregnancy and lactation. Health Expectations, 22 (5), 1013–1027. https://doi.org/10.1111/hex.12910
  37. Italia, S., Wolfenstetter, S. B., Teuner, C. M. (2014). Patterns of Complementary and Alternative Medicine (CAM) use in children: a systematic review. European Journal of Pediatrics, 173 (11), 1413–1428. https://doi.org/10.1007/s00431-014-2300-z
  38. Chiru, T., Fursenco, C., Ciobanu, N., Dinu, M., Popescu, E., Ancuceanu, R. et al. (2020). Use of medicinal plants in complementary treatment of the common cold and influenza – Perception of pharmacy customers in Moldova and Romania. Journal of Herbal Medicine, 21, 100346. https://doi.org/10.1016/j.hermed.2020.100346
  39. European Union herbal monograph on Vaccinium myrtillus L., fructus siccus (2015). European Medicines Agency. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/draft-european-union-herbal-monograph-vaccinium-myrtillus-l-fructus-siccus_en.pdf
  40. European Union herbal monograph on Vaccinium myrtillus L., fructus recens (2015). European Medicines Agency. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-vaccinium-myrtillus-l-fructus-recens_en.pdf
  41. Ansary, J., Forbes-Hernández, T. Y., Gil, E., Cianciosi, D., Zhang, J., Elexpuru-Zabaleta, M. et al. (2020). Potential Health Benefit of Garlic Based on Human Intervention Studies: A Brief Overview. Antioxidants, 9 (7), 619. https://doi.org/10.3390/antiox9070619
  42. European Union herbal monograph on Allium sativum L., bulbus (2016). European Medicines Agency. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/draft-european-union-herbal-monograph-allium-sativum-l-bulbus_en.pdf
  43. Sahidur, M. R., Islam, S., Jahurul, M. H. A. (2023). Garlic (Allium sativum) as a natural antidote or a protective agent against diseases and toxicities: A critical review. Food Chemistry Advances, 3, 100353. https://doi.org/10.1016/j.focha.2023.100353
  44. European Union herbal monograph on Aloe barbadensis Mill. and on Aloe (various species, mainly Aloe ferox Mill. and its hybrids), folii succus siccatus (2016). European Medicines Agency. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-aloe-barbadensis-mill-and-aloe-various-species-mainly-aloe-ferox-mill-and-its-hybrids-folii-succus-siccatus_en.pdf
  45. Hekmatpou, D., Mehrabi, F., Rahzani, K., Aminiyan, A. (2019). The Effect of Aloe Vera Clinical Trials on Prevention and Healing of Skin Wound: A Systematic Review. Iranian Journal of Medical Sciences, 44 (1), 1–9.
  46. Kennedy, D. A., Lupattelli, A., Koren, G., Nordeng, H. (2016). Safety classification of herbal medicines used in pregnancy in a multinational study. BMC Complementary and Alternative Medicine, 16 (1). https://doi.org/10.1186/s12906-016-1079-z
  47. Im, H. B., Ghelman, R., Portella, C. F. S., Hwang, J. H., Choi, D., Kunwor, S. K. et al. (2023). Assessing the safety and use of medicinal herbs during pregnancy: a cross-sectional study in São Paulo, Brazil. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1268185
  48. Zheng, T., Yao, D., Chen, W., Hu, H., Ung, C. O. L., Harnett, J. E. (2019). Healthcare providers’ role regarding the safe and appropriate use of herbal products by breastfeeding mothers: A systematic literature review. Complementary Therapies in Clinical Practice, 35, 131–147. https://doi.org/10.1016/j.ctcp.2019.01.011
Research on the use of medicinal plant materials and herbal-based medicines in the treatment of children, pregnant and breastfeeding women

Downloads

Published

2026-04-30

How to Cite

Raal, A., Nikker, E., Ilina, T., Kovalyova, A., & Koshovyi, O. (2026). Research on the use of medicinal plant materials and herbal-based medicines in the treatment of children, pregnant and breastfeeding women. ScienceRise: Pharmaceutical Science, (2 (60), 71–81. https://doi.org/10.15587/2519-4852.2026.359138

Issue

No. 2 (60) (2026)

Section

Pharmaceutical Science

License

Copyright (c) 2026 Ain Raal, Elen Nikker, Tetiana Ilina, Alla Kovalyova, Oleh Koshovyi

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons Attribution 4.0 International License copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.

3. Authors have the right to store the final accepted version of the article in an institutional, thematic, or any other repository to ensure visibility and accessibility.